
¸ð¹ßÇÐ : ¾Èµå·Î°ÕÅ»¸ðÁõ
- ÀúÀÚ(±Û)´ëÇѸð¹ßÇÐȸ±³°ú¼ÆíÂùÀ§¿øÈ¸
- ÃâÆÇ»çÁ¤¿ìÀÇÇмÀû
- ¹ßÇàÀÏ2021³â 05¿ù 31ÀÏ
Å»¸ð¿Í ÇÇºÎ¾Ï ºÐ¾ßÀÇ ±ÇÀ§ÀÚ
°ÈÆ ±³¼ö´Â °¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿øÀÇ ÇǺΰú ±³¼ö·Î, Å»¸ð¿Í ÇÇºÎ¾Ï ºÐ¾ßÀÇ ±ÇÀ§ÀÚ´Ù.
¸ð¹ßÁúȯ°ú ÇǺÎÁ¾¾ç¿¡ ´ëÇÑ Á¤È®ÇÑ Áø´Ü°ú ¸ÂÃãÇü Ä¡·á¸¦ °Á¶Çϸç, ȯÀڵ鿡°Ô ½Å·Ú¸¦ ÁÖ´Â ÀÇ»ç·Î ¾Ë·ÁÁ® ÀÖ´Ù.
°¡Å縯´ëÇб³ Àǰú´ëÇÐÀ» Á¹¾÷ÇÏ°í µ¿ ´ëÇпø¿¡¼ ¹Ú»çÇÐÀ§¸¦ ÃëµæÇÏ¿´À¸¸ç, ij³ª´Ù ºê¸®Æ¼½ÃÄ÷³ºñ¾Æ´ëÇб³ ¿¬±¸ ±³¼ö ½ÃÀýºÎÅÍ Å»¸ð ¿¬±¸¿¡ ¸ÅÁøÇØ ¿Ô´Ù. ±×ÀÇ ¿¬±¸´Â ÁßÁõ ¿øÇüÅ»¸ð ȯÀÚ Ä¡·á¸¦ À§ÇÑ ±âÃÊ ¹× ÀÓ»ó ¿¬±¸¸¦ Æ÷ÇÔÇϸç, Çѱ¹°úÇбâ¼ú´ÜüÃÑ¿¬ÇÕȸ °úÇбâ¼ú ¿ì¼ö³í¹®»óÀ» ¼ö»óÇÏ´Â µî ÇмúÀû ¼º°ú¸¦ ÀÎÁ¤ ¹Þ¾Ò´Ù.
´ëÇѸð¹ßÇÐȸ ȸÀå, ´ëÇÑÇǺΰúÇÐȸ °í½ÃÀÌ»ç ¹× Ãѹ«ÀÌ»çÁ÷À» ¼öÇàÇØ ¿ÔÀ¸¸ç, ´ëÇÑÇǺΰúÇÐȸ Á¦62´ë Â÷±â ȸÀåÀ¸·Î ¼±ÃâµÇ¾î 2024³â 1¿ùºÎÅÍ 2³â°£ Àӱ⸦ ¼öÇàÇϰí ÀÖ´Ù.
Á¦ ¸ñ | A phase 3, randomized, multi-center clinical trial to evaluate the efficacy and safety of Neu-BoNT/A in treatment of primary axillary hyperhidrosis | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2022 | ¹ßÇ¥Áö | Aesthetic Plast Surg |
Á¦ ¸ñ | Impact of pediatric alopecia areata on quality of life of patients and their family members: A nationwide multicenter questionnaire study | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2022 | ¹ßÇ¥Áö | Ann Dermatol |
Á¦ ¸ñ | Long-term effectiveness and safety of dutasteride versus finasteride in patients with male androgenic alopecia in south korea: A multicentre chart review study | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2022 | ¹ßÇ¥Áö | Ann Dermatol |
Á¦ ¸ñ | Ex vivo treatment with allogenic mesenchymal stem cells of a healthy donor on peripheral blood mononuclear cells of patients with severe alopecia areata: targeting dysregulated T cells and the acquisition of immunotolerance | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2022 | ¹ßÇ¥Áö | Int J Mol Sci |
Á¦ ¸ñ | Preventive effects of a human hematopoietic mesenchymal stem cell (hHMSC) therapy in ovalbumin-induced food allergy | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2022 | ¹ßÇ¥Áö | Biomedicines |
Á¦ ¸ñ | Thirty years (and more) of hair research societies | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2021 | ¹ßÇ¥Áö | Skin Appendage Disord |
Á¦ ¸ñ | A nationwide multicentre cross-sectional questionnaire study on the use of non-dermatologic facilities among patients with hair loss | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2021 | ¹ßÇ¥Áö | J Eur Acad Dermatol Venereol |
30³â°£ ¸ð¹ß (Å»¸ð, ¸ð°£Áúȯ), µÎÇÇÁúȯ ¹× ÇǺÎÁ¾¾ç(ÇǺξÏ) ºÐ¾ß Áø·á ¹× ¿¬±¸¸¦ Áö¼ÓÇØ ¿À°í ÀÖ½À´Ï´Ù.
Á¤È®ÇÑ Áø´Ü°ú ±×¿¡ µû¸¥ ÀûÀýÇÑ Ä¡·á
´ëºÎºÐÀÇ ÁúȯÀÌ ¸¸¼ºº´ÀÎ ÇǺΰú ¿µ¿ªÀÇ ÁúȯÀº ²ÙÁØÇÔ°ú Àγ»½ÉÀÌ ÇÊ¿äÇÑ °æ¿ì°¡ ´Ù¹Ý»ç·Î ´ã´çÀÇ»ç¿ÍÀÇ ±»°ÇÇÑ ½Å·Ú°¡ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.
°¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿øÀº 80¿© ³âÀÇ °¡Å縯 ÀÇ·á ¿ª·®À» ¹ÙÅÁÀ¸·Î, ÃÖ÷´Ü Àåºñ, ¾ÈÀüȯ ȯ°æ, ¿ì¼öÇÑ Áø·á ½Ã½ºÅÛÀ» °®Ãß°í ÀÖ½À´Ï´Ù. À̽Ä, ½ÉÀå, ¾Ï µî ÁßÁõ Áúȯ °í°´µé¿¡°Ô ¿ì¼öÇÑ ÀÇ·áÁøÀÌ ¼öÁØ ³ôÀº Ä¡·á¸¦ Á¦°øÇϸç, ÀÀ±ÞÀÇ·á¼¾ÅÍ¿Í ¼Ò¾ÆÀÀ±Þ½ÇÀ» ¿î¿µÇÏ¿© Áö¿ª»çȸÀÇ ÀÀ±Þ ȯÀڵ鿡°Ô ÇʼöÀûÀÎ ÀÇ·á ¼ºñ½º¸¦ Áö¿øÇÕ´Ï´Ù. ¶ÇÇÑ, °¡Å縯 ÀÇ·á±â°üÀ¸·Î ÀÇ·á Ãë¾à°èÃþÀ» Áö¿øÇÏ´Â µîÀÇ »çȸ°øÇå Ȱµ¿À» Áö¼ÓÀûÀ¸·Î Àü°³Çϰí ÀÖ½À´Ï´Ù.
¼¿ïƯº°½Ã ÀºÆò±¸ ÅëÀÏ·Î 1021